Overview
Selank is a synthetic peptide analogue of tuftsin, an endogenous immunomodulatory tetrapeptide. Extending the tuftsin sequence improves its metabolic stability, and Selank has become a widely referenced research compound for exploring anxiolytic pathways without the sedative or dependence liabilities associated with conventional benzodiazepine-class research comparators.
Nova Biolabs supplies Selank 10mg in lyophilised form from Indonesia domestic stock, HPLC-verified at >98% purity.
Key Research Areas
Anxiolytic Pathway Research
Selank is studied for its anxiolytic-like effects in animal models, investigated as a research alternative that avoids sedation and motor-impairment endpoints.
GABA & Serotonin Modulation
Investigated for its modulatory effects on GABAergic and serotonergic signalling systems relevant to mood and stress-response research.
Neuroimmune Signalling
As a tuftsin analogue, Selank is studied for immunomodulatory activity and crosstalk between neural and immune signalling pathways.
BDNF Expression Research
Explored alongside related neuropeptides for its potential influence on brain-derived neurotrophic factor (BDNF) expression models.
Product Specifications
| Format | Lyophilised powder |
| Quantity | 10mg per vial |
| Purity | >98% (HPLC verified) |
| Storage | Refrigerate at 2–8°C. Stable 24 months lyophilised. |
| Origin | Indonesia domestic stock |
| Research use | In vitro / laboratory use only |